Влияние инсерционно-делеционного полиморфизма гена ангиотензинпревращающего фермента на развитие, прогрессирование и эффективность терапии диабетической нефропатии у больных сахарным диабетом типа 1
https://doi.org/10.18705/1607-419X-2004-10-4-194-196
Аннотация
Об авторах
Ж. В. ШуцкаяРоссия
О. О. Егорова
Россия
Ю. Г. Надь
Россия
А. С. Стройкова
Россия
А. В. Папаян
Россия
Е. И. Шварц
Россия
Список литературы
1. Doria A., Warram J.H., Krolewski A.S. Genetic susceptibility to nephropathy in IDDM: from epidemiology to molecular genetics. Diabetes 1995: 14: 287-314.
2. Krolewski A.S., Quinn I., Angelico M.C., Warram J.H. Familial factors determine the development of diabetic nephropathy inpatient with IDDM. Diabetologia 1996; 39: 940-5.
3. Bjorck S., Blohm G., Sytven C., Mulec H. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Nephrol Dial Transplant 1997; 12 (Suppl. 2): 67-70.
4. Marre M., Bernadet P., Gallois Y. et al. Relationship between angiotensin I converting enzyme gone polymorphism, plasma levels, and diabetic retinal and renal complications, Diabetes 1997: 47: 1585-95.
5. Parving H.H., Jacobsen P., Tarnow L. et al. Effect of detection polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. HMJ 1996; 313: 591-4.
6. Schmidt S., Schone N., Ritz E. The Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy. Kidney Int 1995; 47: 1176-81.
7. Parving H.H., Hommel E., Smidt U.M. Protection of kidney and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Brit Med J 1988; 27: 1086-91.
8. Rigat B., Hubert C., Alhenc-Gelas F. et al. An insertion - deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: l343-6.
9. Mogensen C., Christensen C., Vittingbus P. The stages in diabetic renal disease with emphasis on the stage of incipient nephropathy. Diabetes 1983; 32: 64-78.
10. Blin N., Stafford D.W. A general method for isolation of high molecular weight DNA from eucaryotes. Nucleic Acid Res 1976; 3: 2303.
11. Tarnow L., Cambien F., Rossing P. et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I -converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-94.
12. Yoshida H., Kon V., Ichikawa I. Polymorphism of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 1996; 50: 732-44.
13. Дедов И.И.,. Фадеев В.В. Введение в диабетологию. М., 1998: с. 153.
14. Van Essen G.G., Rensma P.L., de Zeeuw D. et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of reno-protective therapy. Lancet 1996; 347: 94-5.
15. Odawara M., Matsunuma A., Yamashita K. Mistyping frequency of angiotensin -converting enzyme gene polymorphysm and an improved method for its avoidance. Human Genet 1997: 100: 163-6.
Рецензия
Для цитирования:
Шуцкая Ж.В., Егорова О.О., Надь Ю.Г., Стройкова А.С., Папаян А.В., Шварц Е.И. Влияние инсерционно-делеционного полиморфизма гена ангиотензинпревращающего фермента на развитие, прогрессирование и эффективность терапии диабетической нефропатии у больных сахарным диабетом типа 1. Артериальная гипертензия. 2004;10(4):194-196. https://doi.org/10.18705/1607-419X-2004-10-4-194-196
For citation:
Shutskaya Zh.V., Yegorova O.O., Nad Yu.C., Stroikova A.S., Papayan A.V., Shvarts Ye.I. Impact of insertion-deletion polymorphism of angiotensin-convcrting enzyme gene on the development and progression of diabetic nephropathy and efficiency of its therapy in patients with type 1 diabetes mellitus. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2004;10(4):194-196. (In Russ.) https://doi.org/10.18705/1607-419X-2004-10-4-194-196